Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
skin cancer
Pharma
Huyabio's HDAC inhibitor scores in phase 3 melanoma study
Huyabio's HDAC inhibitor HBI-8000 has succeeded in combo with Bristol Myers Squibb’s Opdivo in a phase 3 trial of patients with advanced skin cancer.
Kevin Dunleavy
Jul 14, 2026 10:48am
Sun Pharma brings skin cancer awareness to Super Bowl ‘SUNday’
Feb 5, 2026 8:00am
Almirall, Biofrontera kick off AK social media challenge
May 2, 2025 11:18am
Checkpoint passes FDA checkpoint for PD-L1 drug Unloxcyt
Dec 16, 2024 10:59am
Castle Biosciences taps ‘Real Housewife’ for melanoma awareness
Jul 23, 2024 12:23pm
Almirall urges sun-chasers to 'Stay Vigilant' in new AK campaign
May 30, 2024 11:37am
